- Home
- CTNM vs TSI Comparison
CTNM vs TSI Comparison
Compare CTNM & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- TSI
- Stock Information
- Founded
- CTNM 2009
- TSI 1987
- Country
- CTNM United States
- TSI United States
- Employees
- CTNM N/A
- TSI N/A
- Industry
- CTNM
- TSI Investment Managers
- Sector
- CTNM
- TSI Finance
- Exchange
- CTNM Nasdaq
- TSI Nasdaq
- Market Cap
- CTNM 248.7M
- TSI 236.5M
- IPO Year
- CTNM 2024
- TSI N/A
- Fundamental
- Price
- CTNM $12.16
- TSI N/A
- Analyst Decision
- CTNM Strong Buy
- TSI
- Analyst Count
- CTNM 5
- TSI 0
- Target Price
- CTNM $22.20
- TSI N/A
- AVG Volume (30 Days)
- CTNM 194.4K
- TSI 106.8K
- Earning Date
- CTNM 11-05-2025
- TSI 01-01-0001
- Dividend Yield
- CTNM N/A
- TSI 7.46%
- EPS Growth
- CTNM N/A
- TSI N/A
- EPS
- CTNM N/A
- TSI N/A
- Revenue
- CTNM N/A
- TSI N/A
- Revenue This Year
- CTNM N/A
- TSI N/A
- Revenue Next Year
- CTNM N/A
- TSI N/A
- P/E Ratio
- CTNM N/A
- TSI N/A
- Revenue Growth
- CTNM N/A
- TSI N/A
- 52 Week Low
- CTNM $3.35
- TSI $4.48
- 52 Week High
- CTNM $20.24
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- CTNM 56.27
- TSI 45.73
- Support Level
- CTNM $10.65
- TSI $4.91
- Resistance Level
- CTNM $12.14
- TSI $4.96
- Average True Range (ATR)
- CTNM 0.92
- TSI 0.03
- MACD
- CTNM -0.21
- TSI -0.01
- Stochastic Oscillator
- CTNM 34.98
- TSI 23.33
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.